Abstract
Steinert's disease (myotonic dystrophy type 1; MD) is caused by a CTG trinucleotide expansion on 19q13.3. Although the pathogenic mechanism underlying multisystem involvement in MD is still unclear, a role of oxidative stress in this disease has been suggested. We investigated 39 MD patients to assess the plasma concentration of advanced oxidation protein products (AOPPs) and γ-glutamyltransferase (GGT) and related them to clinical severity scores. Plasma AOPP levels (p=0.021), total serum GGT activity (p=0.0005) and GGT activity associated with low-density lipoprotein (p=0.0021) were significantly higher in patients than in controls. There was significant correlation between serum GGT levels and AOPPs (r=0.5831; p=0.0022). A statistically significant increase in serum GGT with age was found in MD patients (p=0.0193). Receiver operating characteristic curve analysis showed that higher AOPP levels were significantly associated with extra-muscular signs of the disease, i.e., cataracts and heart involvement (area under the curve±SE=0.908±0.083), but not with muscular involvement. The concomitant increment in GGT and AOPPs indicates a possible role of oxidative stress in the pathogenesis of MD type 1, while the association of increased AOPP levels with extra-muscular signs of the disease suggests that individual susceptibility to oxidative stress can modulate the extra-muscular phenotype of the disease.
References
1. Shaw DJ, Harper PS. Myotonic dystrophy: developments in molecular genetics. Br Med Bull 1989; 45: 745–59. 10.1093/oxfordjournals.bmb.a072355Search in Google Scholar
2. Harper PS, editor. Myotonic dystrophy. Major series in neurology. London: WB Saunders, 1989. Search in Google Scholar
3. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, et al. Molecular basis of myotonic dystro-phy: expansion of trinucleotide (CTG) repeat at 3′ end of a transcription encoding a protein kinase family member. Cell 1992; 68: 799–808. 10.1016/0092-8674(92)90154-5Search in Google Scholar
4. Fu YH, Pizzuti A, Fenwick RG Jr, King JR, Rajnarayan S, Dunne PW, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992; 255: 1256–8. 10.1126/science.1546326Search in Google Scholar
5. Usuki F, Ishiura S. Expanded CTG repeats in myotonin protein kinase increase susceptibility to oxidative stress. NeuroReport 1998; 9: 2291–6. 10.1097/00001756-199807130-00027Search in Google Scholar
6. Ihara Y, Mori A, Hayabara T, Namba R, Nobukuni K, Sato K, et al. Free radicals, lipid peroxides and antioxidants in blood of patients with myotonic dystrophy. J Neurol 1995; 242: 119–22. 10.1007/BF00936882Search in Google Scholar
7. Ono S, Kurisaki H, Inouye K, Mannen T. Ragged-red fibers in myotonic dystrophy. J Neurol Sci 1986; 74: 247–55. 10.1016/0022-510X(86)90110-3Search in Google Scholar
8. Sahashi K, Tanaka M, Tashiro M, Ohno K, Ibi T, Takahashi A, et al. Increased mitochondrial DNA deletions in the skeletal muscle of myotonic dystrophy. Gerontology 1992; 38: 18–29. 10.1159/000213303Search in Google Scholar
9. Folkers K, Simonsen R. Two successful double-blind trials with coenzyme Q10 (vitamin Q10) on musculardystrophies and neurogenic atrophies. Biochim Biophys Acta 1995; 1271: 281–6. 10.1016/0925-4439(95)00040-BSearch in Google Scholar
10. Siciliano G, Mancuso M, Tedeschi D, Manca ML, Renna MR, Lombardi V, et al. Coenzyme Q10, exercise lactate and CTG trinucleotide expansion in myotonic dystrophy. Brain Res Bull 2001; 56: 405–10. 10.1016/S0361-9230(01)00653-0Search in Google Scholar
11. Kalousova M, Skrha J, Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 2002; 51: 597–604. Search in Google Scholar
12. Paolicchi A, Dominici S, Pieri L, Maellaro E, Pompella A. Glutathione catabolism as a signaling mechanism. Biochem Pharmacol 2002; 64: 1027–35. 10.1016/S0006-2952(02)01173-5Search in Google Scholar
13. Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 2003; 66: 1499–503. 10.1016/S0006-2952(03)00504-5Search in Google Scholar
14. Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004; 38: 535–9. 10.1080/10715760410001694026Search in Google Scholar
15. Gennarelli M, Pavoni M, Amicucci P, Novelli G, Dallapiccola B. A single polymerase chain reaction-based protocol for detecting normal and expanded alleles in myotonic dystrophy. Diagn Mol Pathol 1998; 7: 135–7. 10.1097/00019606-199806000-00002Search in Google Scholar
16. Gennarelli M, Novelli G, Andreasi Bassi F, Martorell L, Cornet M, Menegazzo E, et al. Prediction of myotonic dystrophy clinical severity based on the number of intragenic [CTG]n trinucleotide repeats. Am J Med Genet 1996; 65: 342–7. 10.1002/(SICI)1096-8628(19961111)65:4<342::AID-AJMG18>3.0.CO;2-USearch in Google Scholar
17. Mathieu J, De Braekeleer M, Prevost C, Boily C. Myotonic dystrophy: clinical assessment of muscular disability in an isolated population with presumed homogeneous mutation. Neurology 1992; 42: 203–8. 10.1212/WNL.42.1.203Search in Google Scholar
18. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304–13. 10.1038/ki.1996.186Search in Google Scholar
19. Huseby NE, Stromme JH. Practical points regarding routine determination of gamma-glutamyl transferase (gamma-GT) in serum with a kinetic method at 37°C. Scand J Clin Lab Invest 1974; 34: 357–63. 10.3109/00365517409049892Search in Google Scholar
20. Ronnemaa T, Alaranta H, Viikari J, Tilvis R, Falck B. Increased activity of serum gamma-glutamyltransferase in myotonic dystrophy. Acta Med Scand 1987; 222: 267–73. 10.1111/j.0954-6820.1987.tb10669.xSearch in Google Scholar
21. Huseby NE. Multiple forms of serum gamma-glutamyltransferase. Association of the enzyme with lipoproteins. Clin Chim Acta 1982; 124: 103–12. 10.1016/0009-8981(82)90324-2Search in Google Scholar
22. Schiele F, Guilmin AM, Detienne H, Siest G. Gamma-glutamyltransferase activity in plasma: statistical distributions, individual variations, and reference intervals. Clin Chem 1997; 23: 1023–8. 10.1093/clinchem/23.6.1023Search in Google Scholar
23. Tapscott SJ. Deconstructing myotonic dystrophy. Science 2000; 289: 1701–2. 10.1126/science.289.5485.1701Search in Google Scholar PubMed
©2005 by Walter de Gruyter Berlin New York